| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0058 | 1 |